Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | -100.00K | -161.00K | -954.00K | -208.00 | ― |
EBITDA | 0.00 | -3.00 | -3.20M | -1.36M | -136.00K |
Net Income | -836.00K | -1.92M | -3.37M | -1.60M | 861.14K |
Balance Sheet | |||||
Total Assets | 1.87M | 1.45M | 1.14M | 234.97K | 33.67K |
Cash, Cash Equivalents and Short-Term Investments | 760.36K | 73.20K | 10.15K | 64.28K | 19.41K |
Total Debt | 1.44M | 1.44M | 1.03M | 160.00K | 825.79K |
Total Liabilities | 4.80M | 3.66M | 3.09M | 1.65M | 2.83M |
Stockholders Equity | -2.93M | -2.22M | -1.95M | -1.42M | -2.80M |
Cash Flow | |||||
Free Cash Flow | -67.84K | -1.79M | -4.18M | -1.19M | -147.12K |
Operating Cash Flow | -67.84K | -1.79M | -3.20M | -1.19M | -147.12K |
Investing Cash Flow | 0.00 | 0.00 | -980.56K | 0.00 | 0.00 |
Financing Cash Flow | 0.00 | 1.85M | 3.15M | 1.24M | 161.52K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
64 Neutral | $10.73B | 15.74 | 7.60% | 2.01% | 2.75% | -15.09% | |
52 Neutral | C$51.29M | 1,685.71 | -3.01% | ― | 63.49% | -133.70% | |
45 Neutral | C$43.09M | ― | -134.39% | ― | 114.81% | 71.94% | |
41 Neutral | C$29.02M | ― | -419.23% | ― | -27.40% | 23.40% | |
22 Underperform | C$8.69M | ― | 55.19% | ― | ― | 64.71% | |
― | C$74.63M | 8.84 | 42.36% | ― | ― | ― | |
36 Underperform | C$7.81M | ― | -336.15% | ― | -58.04% | -71.29% |
BacTech Environmental Corporation has secured CBOE approval for a royalty sale to Silver Crown Royalties Inc., providing a significant boost to BacTech’s financial outlook. The deal strengthens BacTech’s balance sheet with potential CAD$4 million in shares and offers upfront capital for its bioleaching facility in Ecuador, while maintaining focus on core operations. This 10-year agreement ensures long-term collaboration, aligning financial support with project milestones.